Literature DB >> 30218009

Correction: NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL.

C Prieto1, B López-Millán1, H Roca-Ho1, R W Stam2,3, D Romero-Moya1, F J Rodríguez-Baena4, A Sanjuan-Pla1, V Ayllón4, M Ramírez5, M Bardini6, P De Lorenzo7, M G Valsecchi7, M Stanulla8, M Iglesias9, P Ballerini10, Á M Carcaboso11, J Mora11, F Locatelli12, A Bertaina12, L Padilla13, Juan Carlos Rodríguez-Manzaneque4, C Bueno14,15, P Menéndez16,17,18.   

Abstract

The original version of this Article contained an error in the spelling of the author Juan Carlos Rodriguez-Manzaneque, which was incorrectly given as J Carlos Rodríguez-Manzaneque. This has now been corrected in both the PDF and HTML versions of the Article.

Entities:  

Year:  2018        PMID： 30218009     DOI： 10.1038/s41375-018-0236-4

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


  1 in total

1.  Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children.

Authors:  Chao Gao; Shu-Guang Liu; Zhi-Xia Yue; Yi Liu; Jing Liang; Jun Li; Yuan-Yuan Zhang; Jiao-Le Yu; Ying Wu; Wei Lin; Hu-Yong Zheng; Rui-Dong Zhang
Journal:  Cancer Cell Int       Date:  2019-11-14       Impact factor: 5.722
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.